Xerostomia (Dry Mouth) Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Dry mouth, or xerostomia (zeer-o-STOE-me-uh), refers to a condition in which the salivary glands in your mouth don't make enough saliva to keep your mouth wet. Dry mouth is often due to the side effect of certain medications or aging issues or as a result of radiation therapy for cancer.

The global market for Xerostomia (Dry Mouth) Therapeutics was estimated to be worth US$ 684 million in 2023 and is forecast to a readjusted size of US$ 837.9 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

Xerostomia (Dry Mouth) Therapeutics Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Xerostomia (Dry Mouth) Therapeutics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Xerostomia (Dry Mouth) Therapeutics by region & country, by Type, and by Application.

The Xerostomia (Dry Mouth) Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Xerostomia (Dry Mouth) Therapeutics.

Market Segmentation

• Report Metric

• Details

• Report Title

• Xerostomia (Dry Mouth) Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Forecasted Market Size in 2030

• US$ 837.9 million

• CAGR(2024-2030)

• 2.9%

• Market Size Available for Years

• 2019-2030

• Global Xerostomia (Dry Mouth) Therapeutics Companies Covered

• GlaxoSmithKline plc, Church & Dwight, Inc., Colgate-Palmolive Company, Hikma Pharmaceuticals PLC, Pendopharm, Sun Pharmaceuticals Industries Ltd., Lupin Pharmaceuticals, Inc., Pfizer, Inc., Parnell Pharmaceuticals, Inc., Acacia Pharma, OraCoat

• Global Xerostomia (Dry Mouth) Therapeutics Market, by Region

• North America (U.S., Canada, Mexico)

  Europe (Germany, France, UK, Italy, etc.)

  Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

  South America (Brazil, etc.)

  Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

• Global Xerostomia (Dry Mouth) Therapeutics Market, Segment by Type

• Salivary Stimulants

  Salivary Substitutes

  Dentifrices

• Global Xerostomia (Dry Mouth) Therapeutics Market, Segment by Application

• OTC

  Prescription

• Forecast Units

• USD million in value

• Report Coverage

• Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Xerostomia (Dry Mouth) Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Xerostomia (Dry Mouth) Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Xerostomia (Dry Mouth) Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Xerostomia (Dry Mouth) Therapeutics Product Introduction
    1.2 Global Xerostomia (Dry Mouth) Therapeutics Market Size Forecast
        1.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030)
        1.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume (2019-2030)
        1.2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Price (2019-2030)
    1.3 Xerostomia (Dry Mouth) Therapeutics Market Trends & Drivers
        1.3.1 Xerostomia (Dry Mouth) Therapeutics Industry Trends
        1.3.2 Xerostomia (Dry Mouth) Therapeutics Market Drivers & Opportunity
        1.3.3 Xerostomia (Dry Mouth) Therapeutics Market Challenges
        1.3.4 Xerostomia (Dry Mouth) Therapeutics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Xerostomia (Dry Mouth) Therapeutics Players Revenue Ranking (2023)
    2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Company (2019-2024)
    2.3 Global Xerostomia (Dry Mouth) Therapeutics Players Sales Volume Ranking (2023)
    2.4 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Company Players (2019-2024)
    2.5 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Company (2019-2024)
    2.6 Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Xerostomia (Dry Mouth) Therapeutics
    2.9 Xerostomia (Dry Mouth) Therapeutics Market Competitive Analysis
        2.9.1 Xerostomia (Dry Mouth) Therapeutics Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Xerostomia (Dry Mouth) Therapeutics Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xerostomia (Dry Mouth) Therapeutics as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Salivary Stimulants
        3.1.2 Salivary Substitutes
        3.1.3 Dentifrices
    3.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Type
        3.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Value, by Type (2019-2030)
        3.2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Value, by Type (%) (2019-2030)
    3.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Type
        3.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, by Type (2019-2030)
        3.3.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, by Type (%) (2019-2030)
    3.4 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 OTC
        4.1.2 Prescription
    4.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Application
        4.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Value, by Application (2019-2030)
        4.2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Value, by Application (%) (2019-2030)
    4.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Application
        4.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, by Application (2019-2030)
        4.3.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, by Application (%) (2019-2030)
    4.4 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region
        5.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (2019-2024)
        5.1.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (2025-2030)
        5.1.4 Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (%), (2019-2030)
    5.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region
        5.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (2019-2024)
        5.2.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (2025-2030)
        5.2.4 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (%), (2019-2030)
    5.3 Global Xerostomia (Dry Mouth) Therapeutics Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        5.4.2 North America Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        5.5.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        5.6.2 Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        5.7.2 South America Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        5.8.2 Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value
        6.2.1 Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.3.2 United States Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.4.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.5.2 China Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.6.2 Japan Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.7.2 South Korea Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.8.2 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019-2030
        6.9.2 India Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Xerostomia (Dry Mouth) Therapeutics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 GlaxoSmithKline plc
        7.1.1 GlaxoSmithKline plc Company Information
        7.1.2 GlaxoSmithKline plc Introduction and Business Overview
        7.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.1.5 GlaxoSmithKline plc Recent Development
    7.2 Church & Dwight, Inc.
        7.2.1 Church & Dwight, Inc. Company Information
        7.2.2 Church & Dwight, Inc. Introduction and Business Overview
        7.2.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.2.5 Church & Dwight, Inc. Recent Development
    7.3 Colgate-Palmolive Company
        7.3.1 Colgate-Palmolive Company Company Information
        7.3.2 Colgate-Palmolive Company Introduction and Business Overview
        7.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.3.5 Colgate-Palmolive Company Recent Development
    7.4 Hikma Pharmaceuticals PLC
        7.4.1 Hikma Pharmaceuticals PLC Company Information
        7.4.2 Hikma Pharmaceuticals PLC Introduction and Business Overview
        7.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.4.5 Hikma Pharmaceuticals PLC Recent Development
    7.5 Pendopharm
        7.5.1 Pendopharm Company Information
        7.5.2 Pendopharm Introduction and Business Overview
        7.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.5.5 Pendopharm Recent Development
    7.6 Sun Pharmaceuticals Industries Ltd.
        7.6.1 Sun Pharmaceuticals Industries Ltd. Company Information
        7.6.2 Sun Pharmaceuticals Industries Ltd. Introduction and Business Overview
        7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.6.5 Sun Pharmaceuticals Industries Ltd. Recent Development
    7.7 Lupin Pharmaceuticals, Inc.
        7.7.1 Lupin Pharmaceuticals, Inc. Company Information
        7.7.2 Lupin Pharmaceuticals, Inc. Introduction and Business Overview
        7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.7.5 Lupin Pharmaceuticals, Inc. Recent Development
    7.8 Pfizer, Inc.
        7.8.1 Pfizer, Inc. Company Information
        7.8.2 Pfizer, Inc. Introduction and Business Overview
        7.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.8.5 Pfizer, Inc. Recent Development
    7.9 Parnell Pharmaceuticals, Inc.
        7.9.1 Parnell Pharmaceuticals, Inc. Company Information
        7.9.2 Parnell Pharmaceuticals, Inc. Introduction and Business Overview
        7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.9.5 Parnell Pharmaceuticals, Inc. Recent Development
    7.10 Acacia Pharma
        7.10.1 Acacia Pharma Company Information
        7.10.2 Acacia Pharma Introduction and Business Overview
        7.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.10.5 Acacia Pharma Recent Development
    7.11 OraCoat
        7.11.1 OraCoat Company Information
        7.11.2 OraCoat Introduction and Business Overview
        7.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 OraCoat Xerostomia (Dry Mouth) Therapeutics Product Offerings
        7.11.5 OraCoat Recent Development

 8 Industry Chain Analysis
    8.1 Xerostomia (Dry Mouth) Therapeutics Industrial Chain
    8.2 Xerostomia (Dry Mouth) Therapeutics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Xerostomia (Dry Mouth) Therapeutics Sales Model
        8.5.2 Sales Channel
        8.5.3 Xerostomia (Dry Mouth) Therapeutics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Xerostomia (Dry Mouth) Therapeutics Market Trends
    Table 2. Xerostomia (Dry Mouth) Therapeutics Market Drivers & Opportunity
    Table 3. Xerostomia (Dry Mouth) Therapeutics Market Challenges
    Table 4. Xerostomia (Dry Mouth) Therapeutics Market Restraints
    Table 5. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Xerostomia (Dry Mouth) Therapeutics Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Xerostomia (Dry Mouth) Therapeutics
    Table 13. Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xerostomia (Dry Mouth) Therapeutics as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 44. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 45. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Xerostomia (Dry Mouth) Therapeutics Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Xerostomia (Dry Mouth) Therapeutics Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Volume, (2025-2030) & (K MT)
    Table 57. GlaxoSmithKline plc Company Information
    Table 58. GlaxoSmithKline plc Introduction and Business Overview
    Table 59. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 61. GlaxoSmithKline plc Recent Development
    Table 62. Church & Dwight, Inc. Company Information
    Table 63. Church & Dwight, Inc. Introduction and Business Overview
    Table 64. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 66. Church & Dwight, Inc. Recent Development
    Table 67. Colgate-Palmolive Company Company Information
    Table 68. Colgate-Palmolive Company Introduction and Business Overview
    Table 69. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 71. Colgate-Palmolive Company Recent Development
    Table 72. Hikma Pharmaceuticals PLC Company Information
    Table 73. Hikma Pharmaceuticals PLC Introduction and Business Overview
    Table 74. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 76. Hikma Pharmaceuticals PLC Recent Development
    Table 77. Pendopharm Company Information
    Table 78. Pendopharm Introduction and Business Overview
    Table 79. Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Pendopharm Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 81. Pendopharm Recent Development
    Table 82. Sun Pharmaceuticals Industries Ltd. Company Information
    Table 83. Sun Pharmaceuticals Industries Ltd. Introduction and Business Overview
    Table 84. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 86. Sun Pharmaceuticals Industries Ltd. Recent Development
    Table 87. Lupin Pharmaceuticals, Inc. Company Information
    Table 88. Lupin Pharmaceuticals, Inc. Introduction and Business Overview
    Table 89. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 91. Lupin Pharmaceuticals, Inc. Recent Development
    Table 92. Pfizer, Inc. Company Information
    Table 93. Pfizer, Inc. Introduction and Business Overview
    Table 94. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 96. Pfizer, Inc. Recent Development
    Table 97. Parnell Pharmaceuticals, Inc. Company Information
    Table 98. Parnell Pharmaceuticals, Inc. Introduction and Business Overview
    Table 99. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 101. Parnell Pharmaceuticals, Inc. Recent Development
    Table 102. Acacia Pharma Company Information
    Table 103. Acacia Pharma Introduction and Business Overview
    Table 104. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 106. Acacia Pharma Recent Development
    Table 107. OraCoat Company Information
    Table 108. OraCoat Introduction and Business Overview
    Table 109. OraCoat Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. OraCoat Xerostomia (Dry Mouth) Therapeutics Product Offerings
    Table 111. OraCoat Recent Development
    Table 112. Key Raw Materials Lists
    Table 113. Raw Materials Key Suppliers Lists
    Table 114. Xerostomia (Dry Mouth) Therapeutics Downstream Customers
    Table 115. Xerostomia (Dry Mouth) Therapeutics Distributors List
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Xerostomia (Dry Mouth) Therapeutics Product Picture
    Figure 2. Global Xerostomia (Dry Mouth) Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Xerostomia (Dry Mouth) Therapeutics Sales Price (2019-2030) & (USD/MT)
    Figure 6. Xerostomia (Dry Mouth) Therapeutics Report Years Considered
    Figure 7. Global Xerostomia (Dry Mouth) Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Xerostomia (Dry Mouth) Therapeutics Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Xerostomia (Dry Mouth) Therapeutics Revenue in 2023
    Figure 10. Xerostomia (Dry Mouth) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Salivary Stimulants Picture
    Figure 12. Salivary Substitutes Picture
    Figure 13. Dentifrices Picture
    Figure 14. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Xerostomia (Dry Mouth) Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 17. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2019-2030) & (USD/MT)
    Figure 19. Product Picture of OTC
    Figure 20. Product Picture of Prescription
    Figure 21. Global Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Xerostomia (Dry Mouth) Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 24. Global Xerostomia (Dry Mouth) Therapeutics Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2019-2030) & (USD/MT)
    Figure 26. North America Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Xerostomia (Dry Mouth) Therapeutics Sales Volume (%), (2019-2030)
    Figure 38. United States Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Xerostomia (Dry Mouth) Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Xerostomia (Dry Mouth) Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Xerostomia (Dry Mouth) Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 59. Xerostomia (Dry Mouth) Therapeutics Industrial Chain
    Figure 60. Xerostomia (Dry Mouth) Therapeutics Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Dry mouth, or xerostomia (zeer-o-STOE-me-uh), refers to a condition in which the salivary glands in your mouth don't make enough saliva to keep your mouth wet. Dry mouth is often due to the side effect of certain medications or aging issues or as a result of radiation therapy for cancer.

The global market for Xerostomia (Dry Mouth) Therapeutics was estimated to be worth US$ 684 million in 2023 and is forecast to a readjusted size of US$ 837.9 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Xerostomia (Dry Mouth) Therapeutics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Xerostomia (Dry Mouth) Therapeutics by region & country, by Type, and by Application.

The Xerostomia (Dry Mouth) Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Xerostomia (Dry Mouth) Therapeutics.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Xerostomia (Dry Mouth) Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Xerostomia (Dry Mouth) Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Xerostomia (Dry Mouth) Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.